Mon Oct 14 13:39:43 UTC 2024: Desidustat has been discovered at Zydus Lifesciences’s R&D labs, and was recently approved for treatment of anaemia in chronic kidney disease patients
https://www.thehindu.com/
ICMR and Zydus Lifesciences initiate second phase proof-of-concept trial for Desidustat in patients with sickle cell disease
ICMR and Zydus Lifesciences initiate second phase proof-of-concept trial for Desidustat in patients with sickle cell disease
First Piper 